Transcriptional regulation in model organisms: recent progress and clinical implications
- PMID: 31744421
- PMCID: PMC6893401
- DOI: 10.1098/rsob.190183
Transcriptional regulation in model organisms: recent progress and clinical implications
Abstract
In this review, we will summarize model organisms used by scientists in the laboratory, including Escherichia coli, yeast, Arabidopsis thaliana, nematodes, Drosophila, zebrafish, mice and other animals. We focus on the progress in research exploring different types of E. coli in the human body, and the specific molecular mechanisms by which they play a role in humans. First, we discuss the specific transcriptional regulation mechanism of E. coli in cell development, maturation, ageing and longevity, as well as tumorigenesis and development. Then, we discuss how the synthesis of some important substances in cells is regulated and how this affects biological behaviour. Understanding and applying these mechanisms, presumably, can greatly improve the quality of people's lives as well as increase their lifespan. For example, some E. coli can activate certain cells by secreting insulin-like growth factor-1, thus activating the inflammatory response of the body, while other E. coli can inactivate the immune response of the body by secreting toxic factors.
Keywords: Caenorhabditis elegans; Drosophila melanogaster; model organisms; transcriptional regulation.
Conflict of interest statement
We have no competing interests.
Figures




References
-
- Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P. 2007. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice. Arterioscler. Thromb Vasc. Biol. 27, 2684–2690. (10.1161/ATVBAHA.107.156257) - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources